Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis

Hepatology

Volumn 57, Issue 4, 2013, Pages 1498-1508

  Chen, Richy C Y ^a   Naiyanetr, Phornnop ^a,b   Shu, Shang An ^a   Wang, Jinjun ^a   Yang, Guo Xiang ^a   Kenny, Thomas P ^a   Guggenheim, Kathryn C ^a   Butler, Jeffrey D ^a   Bowlus, Christopher ^a   Tao, Mi Hua ^c   Kurth, Mark J ^a   Ansari, Aftab A ^d   Kaplan, Marshall ^e   Coppel, Ross L ^f   Lleo, Ana ^g   Gershwin, M Eric ^a   Leung, Patrick S C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MONASH UNIVERSITY   (Australia)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; BOVINE SERUM ALBUMIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; OCTANOIC ACID; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE E2 SUBUNIT; THIOCTIC ACID; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; BINDING AFFINITY; COHORT ANALYSIS; CONTROLLED STUDY; DISULFIDE BOND; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SEROLOGY;

ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODY SPECIFICITY; AUTOANTIGENS; CASE-CONTROL STUDIES; CHOLANGITIS, SCLEROSING; DIHYDROLIPOYLLYSINE-RESIDUE ACETYLTRANSFERASE; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN M; LIVER CIRRHOSIS, BILIARY; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; XENOBIOTICS;

EID: 84876121192     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26157     Document Type: Article

References (52)

1. Gershwin ME, Mackay IR, Sturgess A, Coppel RL. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 1987; 138: 3525-3531.
2. Hirschfield GM, Heathcote EJ, Gershwin ME. Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 2010; 139: 1481-1496.
3. Selmi C, Mackay IR, Gershwin ME. The autoimmunity of primary biliary cirrhosis and the clonal selection theory. Immunol Cell Biol 2011; 89: 70-80.
4. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: Convenient and inconvenient truths. HEPATOLOGY 2008; 47: 737-745.
5. Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, et al. Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology 2003; 125: 1705-1713.
6. Cha S, Leung PS, Coppel RL, Van de Water J, Ansari AA, Gershwin ME. Heterogeneity of combinatorial human autoantibodies against PDC-E2 and biliary epithelial cells in patients with primary biliary cirrhosis. HEPATOLOGY 1994; 20: 574-583.
7. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010; 9: A247-250.
8. Benson GD, Kikuchi K, Miyakawa H, Tanaka A, Watnik MR, Gershwin ME. Serial analysis of antimitochondrial antibody in patients with primary biliary cirrhosis. Clin Dev Immunol 2004; 11: 129-133.
9. Amano K, Leung PS, Rieger R, Quan C, Wang X, Marik J, et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis: identification of antibodies against a common environmental, cosmetic, and food additive, 2-octynoic acid. J Immunol 2005; 174: 5874-5883.
10. Long SA, Quan C, Van de Water J, Nantz MH, Kurth MJ, Barsky D, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001; 167: 2956-2963.
11. Rieger R, Leung PS, Jeddeloh MR, Kurth MJ, Nantz MH, Lam KS, et al. Identification of 2-nonynoic acid, a cosmetic component, as a potential trigger of primary biliary cirrhosis. J Autoimmun 2006; 27: 7-16.
12. Naiyanetr P, Butler JD, Meng L, Pfeiff J, Kenny TP, Guggenheim KG, et al. Electrophile-modified lipoic derivatives of PDC-E2 elicits anti-mitochondrial antibody reactivity. J Autoimmun 2011.
13. Leung PSC, Lam K, Kurth MJ, Coppel RL, Geshwin ME. Xenobiotics and autoimmunity: does acetamimnophen cause primary biliary cirrhosis? Trends Mol Med 2012; 18: 577-582.
14. Miller FW. Environmental agents and autoimmune diseases. Adv Exp Med Biol 2011; 711: 61-81.
15. Schmidt CW. Questions persist: environmental factors in autoimmune disease. Environ Health Perspect 2011; 119: A249-253.
16. Rieger R, Gershwin ME. The X and why of xenobiotics in primary biliary cirrhosis. J Autoimmun 2007; 28: 76-84.
17. Chang C, Gershwin ME. Drugs and autoimmunity-a contemporary review and mechanistic approach. J Autoimmun 2010; 34: J266-275.
18. Angulo JM, Sigal LH, Espinoza LR. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin Arthritis Rheum 1998; 28: 187-192.
19. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005; 353: 1261-1273.
20. Bambha K, Kim WR, Talwalkar J, Torgerson H, Benson JT, Therneau TM, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125: 1364-1369.
21. Leung PS, Rossaro L, Davis PA, Park O, Tanaka A, Kikuchi K, et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. HEPATOLOGY 2007; 46: 1436-1442.
22. Stravitz RT, Lefkowitch JH, Fontana RJ, Gershwin ME, Leung PS, Sterling RK, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. HEPATOLOGY 2011; 53: 517-526.
23. Wakabayashi K, Lian ZX, Leung PS, Moritoki Y, Tsuneyama K, Kurth MJ, et al. Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease. HEPATOLOGY 2008; 48: 531-540.
24. Moteki S, Leung PS, Coppel RL, Dickson ER, Kaplan MM, Munoz S, et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. HEPATOLOGY 1996; 24: 97-103.
25. Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. HEPATOLOGY 2007; 45: 659-665.
26. Liu H, Norman GL, Shums Z, Worman HJ, Krawitt EL, Bizzaro N, et al. PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis. J Autoimmun 2010; 35: 436-442.
27. Leung PS, Chu KH, Chow WK, Ansari A, Bandea CI, Kwan HS, et al. Cloning, expression, and primary structure of Metapenaeus ensis tropomyosin, the major heat-stable shrimp allergen. J Allergy Clin Immunol 1994; 94: 882-890.
28. Cuatrecasas P. Protein purification by affinity chromatography. Derivatizations of agarose and polyacrylamide beads. J Biol Chem 1970; 245: 3059-3065.
29. Cha S, Leung PS, Gershwin ME, Fletcher MP, Ansari AA, Coppel RL. Combinatorial autoantibodies to dihydrolipoamide acetyltransferase, the major autoantigen of primary biliary cirrhosis. Proc Natl Acad Sci U S A 1993; 90: 2527-2531.
30. Van de Water J, Fregeau D, Davis P, Ansari A, Danner D, Leung P, et al. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol 1988; 141: 2321-2324.
31. Van de Water J, Gershwin ME, Leung P, Ansari A, Coppel RL. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med 1988; 167: 1791-1799.
32. Mao TK, Davis PA, Odin JA, Coppel RL, Gershwin ME. Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis. HEPATOLOGY 2004; 40: 1241-1248.
33. Odin JA, Huebert RC, Casciola-Rosen L, LaRusso NF, Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 2001; 108: 223-232.
34. O'Connor TP, Roche TE, Paukstelis JV. 13C nuclear magnetic resonance study of the pyruvate dehydrogenase-catalyzed acetylation of dihydrolipoamide. J Biol Chem 1982; 257: 3110-3112.
35. Bernal W, Meda F, Ma Y, Bogdanos DP, Vergani D. Disease-specific autoantibodies in patients with acute liver failure: the King's College London Experience. HEPATOLOGY 2008; 47: 1096-1097; author reply 1097.
36. Lleo A, Bowlus CL, Yang GX, Invernizzi P, Podda M, Van de Water J, et al. Biliary apotopes and anti-mitochondrial antibodies activate innate immune responses in primary biliary cirrhosis. HEPATOLOGY 2010; 52: 987-998.
37. Doyle HA, Mamula MJ. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol 2001; 22: 443-449.
38. Doyle HA, Mamula MJ. Autoantigenesis: the evolution of protein modifications in autoimmune disease. Curr Opin Immunol 2012; 24: 112-118.
39. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-717.
40. Stea EA, Routsias JG, Samiotaki M, Panayotou G, Papalambros E, Moutsopoulos HM, et al. Analysis of parotid glands of primary Sjogren's syndrome patients using proteomic technology reveals altered autoantigen composition and novel antigenic targets. Clin Exp Immunol 2007; 147: 81-89.
41. Van den Steen PE, Proost P, Brand DD, Kang AH, Van Damme J, Opdenakker G. Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B. Biochemistry 2004; 43: 10809-10816.
42. Yang ML, Gee AJ, Gee RJ, Zuritalopez CI, Khare S, Clarke S, et al. Lupus autoimmunity altered by cellular methylation metabolism. Autoimmunity 2012 [Epub ahead of print].
43. Cooper GS, Parks CG, Treadwell EL, St Clair EW, Gilkeson GS, Dooley MA. Occupational risk factors for the development of systemic lupus erythematosus. J Rheumatol 2004; 31: 1928-1933.
44. Pollard KM, Lee DK, Casiano CA, Bluthner M, Johnston MM, Tan EM. The autoimmunity-inducing xenobiotic mercury interacts with the autoantigen fibrillarin and modifies its molecular and antigenic properties. J Immunol 1997; 158: 3521-3528.
45. Pollard KM, Pearson DL, Bluthner M, Tan EM. Proteolytic cleavage of a self-antigen following xenobiotic-induced cell death produces a fragment with novel immunogenic properties. J Immunol 2000; 165: 2263-2270.
46. Vas J, Monestier M. Immunology of mercury. Ann N Y Acad Sci 2008; 1143: 240-267.
47. Leung PS, Park O, Tsuneyama K, Kurth MJ, Lam KS, Ansari AA, et al. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J Immunol 2007; 179: 2651-2657.
48. Leung PS, Quan C, Park O, Van de Water J, Kurth MJ, Nantz MH, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003; 170: 5326-5332.
49. Makela O, Ruoslahti E, Seppala IJ. Affinity of IgM and IgG antibodies. Immunochemistry 1970; 7: 917-932.
50. Lleo A, Liao J, Invernizzi P, Zhao M, Bernuzzi F, Ma L, et al. Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis. HEPATOLOGY 2012; 55: 153-160.
51. Lleo A, Selmi C, Invernizzi P, Podda M, Coppel RL, Mackay IR, et al. Apotopes and the biliary specificity of primary biliary cirrhosis. HEPATOLOGY 2009; 49: 871-879.
52. Lleo A, Shimoda S, Ishibashi H, Gershwin ME. Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes. J Gastroenterol 2011; 46( Suppl 1): 29-38.